Indefinite Delivery Contract SPE2DR25D3110
- Not listed
- The federal contract IDV award SPE2DR25D1931 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract aims to establish...
- The federal contract IDV award SPE2DU25D7051 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health...
- The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036. The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide...
- The federal contract IDV award SPE2DR25D6038 is a single-award, unrestricted Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet. The contract covers a broad range of...
- The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
- The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
- The federal contract IDV award SPE2DR25D6041, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
- The federal contract IDV award is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2036, serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic...
- The federal contract IDV award SPE2DR25D1051, issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 with a period of performance through December 31, 2036. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical...
- The federal contract IDV award SPE2DR25D1055, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a single-award Indefinite Delivery Contract (IDC) valued at $9,999,999,999 with Amerisourcebergen Drug Corp as the prime contractor. The contract has a 30-month base period with three 30-month option periods, extending through December 2036. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish prime vendor contracts for...
The federal contract IDV award SPE2DR25D3110 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs through December 2036. This IDC serves as the primary contracting vehicle for the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish prime vendor contracts for worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contracted commodities encompass brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. This unrestricted, fully competitive acquisition will result in multiple regional primary supplier awards, ensuring the Department of Defense's resilience and access to vital pharmaceuticals during contingencies or natural disasters.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/7/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global GEN V Presolicitation | SPE2DX-24-R-0001 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/5 | 2/1/24, 3:44 PM | |
Pharmaceutical Prime Vendor Global GEN V Solicitation | SPE2DX-24-R-0001_SOLICITATION | Defense Logistics Agency Troop Support Medical | Solicitation 2/5 | 3/13/24, 11:08 AM | |
PPVG GEN V Award | SPE2DX-25-D-1000 | Defense Logistics Agency Troop Support Medical | Award Notice 3/5 | 3/7/25, 10:09 AM | |
PPVG GEN V AWARD SPE2DX25D9000 | SPE2DX25D9000 | Defense Logistics Agency Troop Support Medical | Award Notice 4/5 | 3/7/25, 10:14 AM | |
PPVG GEN V AWARD SPE2DX25D8000 | SPE2DX25D8000 | Defense Logistics Agency Troop Support Medical | Award Notice 5/5 | 3/7/25, 10:18 AM |